Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design-Reference-Cited by-同舟云学术

Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design

Published:2012-02 Issue:1 Volume:21 Page:20-26
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Eiermann W.,Bergh J.,Cardoso F.,Conte P.,Crown J.,Curtin N.J.,Gligorov J.,Gusterson B.,Joensuu H.,Linderholm B.K.,Martin M.,Penault-Llorca F.,Pestalozzi B.C.,Razis E.,Sotiriou C.,Tjulandin S.,Viale G.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference74 articles.

1. Triple-negative breast cancer: disease entity or title of convenience;Carey;Nat Rev Clin Oncol,2010

2. Treatment of triple negative metastatic breast cancer: toward individualized targeted treatments or chemosensitisation?;Berrada;Ann Oncol,2010

3. Treatment options for patients with triple negative breast cancer;Santana-Davila;J Hematol Oncol 2010 Published,2010

4. Basal like and triple negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists;Badve;Mod Pathol,2011

5. Triple-negative breast cancer: current state of the art;Rastelli;Tumori,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers;Bioorganic Chemistry;2023-12

2. Novel BH4-BCL-2 Domain Antagonists Induce BCL-2-Mediated Apoptosis in Triple-Negative Breast Cancer;Cancers;2022-10-26

3. Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer;British Journal of Cancer;2021-08-07

4. Triple-Negative Breast Cancer;Oncology in the Precision Medicine Era;2019-12-18

5. Immunotherapy: The end of the "dark age" for metastatic triple‐negative breast cancer?;The Breast Journal;2019-10-14